CERo Therapeutics Holdings Inc.

NASDAQ: CERO
Share price (8/15/25): $8.00
Market cap (8/15/25): $4.129 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

Late quarterly filing notification for Q2 2025

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

ended 12/31/24 FY 2024

Late annual filing notification for FY 2024

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement

Initial registration of new securities

Prospectus supplement

Ownership Filter

Armistice Capital, LLC

Laporte Kathleen

News Filter

Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Announces FDA Orphan Drug Designation Granted to CER-1236 for the Treatment of Acute Myeloid Leukemia

Proxies Filter

Definitive proxy

Preliminary revised proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC